CD44 deficiency contributes to enhanced experimental autoimmune encephalomyelitis: A role in immune cells and vascular cells of the blood-brain barrier

American Journal of Pathology

Volumn 182, Issue 4, 2013, Pages 1322-1336

  Flynn, Kelly M ^a   Michaud, Michael ^a   Madri, Joseph A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; CYTOKINE; HERMES ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD BRAIN BARRIER; BONE MARROW; CD4+ CD25+ T LYMPHOCYTE; CELL ADHESION; CELL COUNT; CELL ISOLATION; CELL MEMBRANE DEPOLARIZATION; CELLS; CENTRAL NERVOUS SYSTEM; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RNA EXTRACTION; TH17 CELL; VASCULAR CELL; WILD TYPE;

ANIMALS; ANTIGENS, CD44; BLOOD-BRAIN BARRIER; BONE MARROW CELLS; CELL ADHESION; CELL MOVEMENT; CELL POLARITY; CHIMERA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; GENE DELETION; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERMEABILITY; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STROMAL CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84875190575     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.003     Document Type: Article

References (69)

1. L. Steinman, and S.S. Zamvil How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis Ann Neurol 60 2006 12 21
2. J. Goverman Autoimmune T cell responses in the central nervous system Nat Rev Immunol 9 2009 393 407
3. A.R. Oliver, G.M. Lyon, and N.H. Ruddle Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice J Immunol 171 2003 462 468
4. K. O'Brien, D.C. Fitzgerald, K. Naiken, K.R. Alugupalli, A.M. Rostami, and B. Gran Role of the innate immune system in autoimmune inflammatory demyelination Curr Med Chem 15 2008 1105 1115
5. A. Reboldi, C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE Nat Immunol 10 2009 514 523
6. H. Kebir, K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation Nat Med 13 2007 1173 1175
7. H. Hofstetter, R. Gold, and H.P. Hartung Th17 cells in MS and experimental autoimmune encephalomyelitis Int MS J 16 2009 12 18
8. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
9. P.R. Mangan, L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb, and C.T. Weaver Transforming growth factor-beta induces development of the T(H)17 lineage Nature 441 2006 231 234
10. J. Huppert, D. Closhen, A. Croxford, R. White, P. Kulig, E. Pietrowski, I. Bechmann, B. Becher, H.J. Luhmann, A. Waisman, and C.R. Kuhlmann Cellular mechanisms of IL-17-induced blood-brain barrier disruption FASEB J 24 2010 1023 1034
11. X. Zhang, D.N. Koldzic, L. Izikson, J. Reddy, R.F. Nazareno, S. Sakaguchi, V.K. Kuchroo, and H.L. Weiner IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells Int Immunol 16 2004 249 256
12. M.J. McGeachy, L.A. Stephens, and S.M. Anderton Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system J Immunol 175 2005 3025 3032
13. W. Chen, W. Jin, N. Hardegen, K.J. Lei, L. Li, N. Marinos, G. McGrady, and S.M. Wahl Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
14. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat Rev Immunol 3 2003 253 257
15. J. Bennett, J. Basivireddy, A. Kollar, K.E. Biron, P. Reickmann, W.A. Jefferies, and S. McQuaid Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE J Neuroimmunol 229 2010 180 191
16. A. Minagar, and J.S. Alexander Blood-brain barrier disruption in multiple sclerosis Mult Scler 9 2003 540 549
17. R.F. Thorne, J.W. Legg, and C.M. Isacke The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events J Cell Sci 117 2004 373 380
18. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion molecules to signalling regulators Nat Rev Mol Cell Biol 4 2003 33 45
19. H.C. DeGrendele, P. Estess, and M.H. Siegelman Requirement for CD44 in activated T cell extravasation into an inflammatory site Science 278 1997 672 675
20. S. Nedvetzki, M. Walmsley, E. Alpert, R.O. Williams, M. Feldmann, and D. Naor CD44 involvement in experimental collagen-induced arthritis (CIA) J Autoimmun 13 1999 39 47
21. K. Mikecz, F.R. Brennan, J.H. Kim, and T.T. Glant Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis Nat Med 1 1995 558 563
22. L. Weiss, S. Slavin, S. Reich, P. Cohen, S. Shuster, R. Stern, E. Kaganovsky, E. Okon, A.M. Rubinstein, and D. Naor Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody Proc Natl Acad Sci U S A 97 2000 285 290
23. S. Katoh, N. Ishii, A. Nobumoto, K. Takeshita, S.Y. Dai, R. Shinonaga, T. Niki, N. Nishi, A. Tominaga, A. Yamauchi, and M. Hirashima Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma Am J Respir Crit Care Med 176 2007 27 35
24. S. Brocke, C. Piercy, L. Steinman, I.L. Weissman, and T. Veromaa Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment Proc Natl Acad Sci U S A 96 1999 6896 6901
25. P. Teder, R.W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P.M. Henson, and P.W. Noble Resolution of lung inflammation by CD44 Science 296 2002 155 158
26. Q. Wang, P. Teder, N.P. Judd, P.W. Noble, and C.M. Doerschuk CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice Am J Pathol 161 2002 2219 2228
27. J. Liang, D. Jiang, J. Griffith, S. Yu, J. Fan, X. Zhao, R. Bucala, and P.W. Noble CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages J Immunol 178 2007 2469 2475
28. G.J. van der Windt, C. van 't Veer, S. Florquin, and T. van der Poll CD44 deficiency is associated with enhanced Escherichia coli-induced proinflammatory cytokine and chemokine release by peritoneal macrophages Infect Immun 78 2010 115 124
29. J. Muto, K. Yamasaki, K.R. Taylor, and R.L. Gallo Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS Mol Immunol 47 2009 449 456
30. P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, S. Haudek, G. Thakker, and N.G. Frangogiannis CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response J Immunol 180 2008 2625 2633
31. R.J. McKallip, M. Fisher, U. Gunthert, A.K. Szakal, P.S. Nagarkatti, and M. Nagarkatti Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: cD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage Infect Immun 73 2005 50 61
32. S. Nedvetzki, E. Gonen, N. Assayag, R. Reich, R.O. Williams, R.L. Thurmond, J.F. Huang, B.A. Neudecker, F.S. Wang, E.A. Turley, and D. Naor RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy Proc Natl Acad Sci U S A 101 2004 18081 18086
33. G. Hutas, E. Bajnok, I. Gal, A. Finnegan, T.T. Glant, and K. Mikecz CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis Blood 112 2008 4999 5006
34. N. Girgrah, M. Letarte, L.E. Becker, T.F. Cruz, E. Theriault, and M.A. Moscarello Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis J Neuropathol Exp Neurol 50 1991 779 792
35. S.A. Back, T.M. Tuohy, H. Chen, N. Wallingford, A. Craig, J. Struve, N.L. Luo, F. Banine, Y. Liu, A. Chang, B.D. Trapp, B.F. Bebo Jr., M.S. Rao, and L.S. Sherman Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation Nat Med 11 2005 966 972
36. W. Knudson, G. Chow, and C.B. Knudson CD44-mediated uptake and degradation of hyaluronan Matrix Biol 21 2002 15 23
37. P.W. Noble Hyaluronan and its catabolic products in tissue injury and repair Matrix Biol 21 2002 25 29
38. E. Pinter, M. Barreuther, T. Lu, B.A. Imhof, and J.A. Madri Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus Am J Pathol 150 1997 1523 1530
39. A.E. Cardona, D. Huang, M.E. Sasse, and R.M. Ransohoff Isolation of murine microglial cells for RNA analysis or flow cytometry Nat Protoc 1 2006 1947 1951
40. D. Graesser, S. Mahooti, T. Haas, S. Davis, R.B. Clark, and J.A. Madri The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis Lab Invest 78 1998 1445 1458
41. D. Graesser, A. Solowiej, M. Bruckner, E. Osterweil, A. Juedes, S. Davis, N.H. Ruddle, B. Engelhardt, and J.A. Madri Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice J Clin Invest 109 2002 383 392
42. H. Guan, P.S. Nagarkatti, and M. Nagarkatti CD44 reciprocally regulates the differentiation of encephalitogenic Th1/Th17 and Th2/regulatory T cells through epigenetic modulation involving DNA methylation of cytokine gene promoters, thereby controlling the development of experimental autoimmune encephalomyelitis J Immunol 186 2011 6955 6964
43. S. Reitsma, D.W. Slaaf, H. Vink, M.A. van Zandvoort, and M.G. oude Egbrink The endothelial glycocalyx: composition, functions, and visualization Pflugers Arch 454 2007 345 359
44. A. Nandi, P. Estess, and M.H. Siegelman Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44 J Biol Chem 275 2000 14939 14948
45. F. Fossiez, O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J.J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, and S. Lebecque T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines J Exp Med 183 1996 2593 2603
46. M.O. Li, and R.A. Flavell TGF-beta: a master of all T cell trades Cell 134 2008 392 404
47. S. Sanjabi, L.A. Zenewicz, M. Kamanaka, and R.A. Flavell Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity Curr Opin Pharmacol 9 2009 447 453
48. E.M. Shevach Mechanisms of foxp3+ T regulatory cell-mediated suppression Immunity 30 2009 636 645
49. R.A. O'Connor, and S.M. Anderton Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease J Neuroimmunol 193 2008 1 11
50. M. Firan, S. Dhillon, P. Estess, and M.H. Siegelman Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44 Blood 107 2006 619 627
51. P.L. Bollyky, B.A. Falk, S.A. Long, A. Preisinger, K.R. Braun, R.P. Wu, S.P. Evanko, J.H. Buckner, T.N. Wight, and G.T. Nepom CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta J Immunol 183 2009 2232 2241
52. G.J. Martinez, Z. Zhang, Y. Chung, J.M. Reynolds, X. Lin, A.M. Jetten, X.H. Feng, and C. Dong Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation J Biol Chem 284 2009 35283 35286
53. L. Zhou, J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function Nature 453 2008 236 240
54. Y.H. Kim, B.K. Choi, S.M. Shin, C.H. Kim, H.S. Oh, S.H. Park, D.G. Lee, M.J. Lee, K.H. Kim, D.S. Vinay, and B.S. Kwon 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T Cells J Immunol 187 2011 1120 1128
55. E. Beurel, W.I. Yeh, S.M. Michalek, L.E. Harrington, and R.S. Jope Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells J Immunol 186 2011 1391 1398
56. X. Guo, A. Ramirez, D.S. Waddell, Z. Li, X. Liu, and X.F. Wang Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling Genes Dev 22 2008 106 120
57. F. Caraci, E. Gili, M. Calafiore, M. Failla, C. La Rosa, N. Crimi, M.A. Sortino, F. Nicoletti, A. Copani, and C. Vancheri TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts Pharmacol Res 57 2008 274 282
58. K.H. Wrighton, X. Lin, and X.H. Feng Phospho-control of TGF-beta superfamily signaling Cell Res 19 2009 8 20
59. M. Martin, K. Rehani, R.S. Jope, and S.M. Michalek Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nat Immunol 6 2005 777 784
60. L.Y. Bourguignon, P.A. Singleton, H. Zhu, and B. Zhou Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells J Biol Chem 277 2002 39703 39712
61. N. Nijenhuis, D. Mizuno, J.A. Spaan, and C.F. Schmidt Viscoelastic response of a model endothelial glycocalyx Phys Biol 6 2009 025014
62. G. Kaya, I. Rodriguez, J.L. Jorcano, P. Vassalli, and I. Stamenkovic Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation Genes Dev 11 1997 996 1007
63. G. Cinamon, V. Grabovsky, E. Winter, S. Franitza, S. Feigelson, R. Shamri, O. Dwir, and R. Alon Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow J Leukoc Biol 69 2001 860 866
64. J.A. Madri, and D. Graesser Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases Dev Immunol 7 2000 103 116
65. K. Takahashi, H. Eto, and K.K. Tanabe Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells Int J Cancer 80 1999 387 395
66. Q. Yu, and I. Stamenkovic Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis Genes Dev 14 2000 163 176
67. Y. Yang, and G.A. Rosenberg MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia Methods Mol Biol 762 2011 333 345
68. J. Esparza, M. Kruse, J. Lee, M. Michaud, and J.A. Madri MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity FASEB J 18 2004 1682 1691
69. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat Rev Neurosci 7 2006 41 53